Global Next-Gen Cancer Diagnostics Market Forecast 2020-2025 with Profiles of 130+ Companies and Impact Assessment of COVID-19
August 25, 2020 07:04 ET
|
Research and Markets
Dublin, Aug. 25, 2020 (GLOBE NEWSWIRE) -- The "Next Generation Cancer Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The scope of this...
Mereo BioPharma Announces Initiation of Placebo-Controlled Phase 1b/2 Clinical Trial with Alvelestat in COVID-19 Respiratory Disease
August 25, 2020 07:00 ET
|
Mereo BioPharma Group plc
LONDON and REDWOOD CITY, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or “the Company”, a clinical-stage biopharmaceutical company focused on...
Chart Industries Signs Definitive Agreement to Divest Cryobiological Products Business for $320 Million to Cryoport, Inc.
August 25, 2020 07:00 ET
|
Chart Industries, Inc.
ATLANTA, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (“Chart”) (NASDAQ: GTLS) today announced that it has signed a definitive agreement to divest its cryobiological products business...
Glory Star New Media Group Holdings Limited’s Third Season of Hallo!Rapper Recorded an 81.8% Increase in Revenues Compared to Its Previous Season
August 25, 2020 07:00 ET
|
Glory Star New Media Group Holdings Limited
BEIJING, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) (“Glory Star” or the “Company”), a leading mobile and online digital media and entertainment...
ADM Endeavors, Inc. (ADMQ) Announces That Its Operating Subsidiary, Just Right Products, Inc., Has Paid Off All Long-Term Debt Obligations
August 25, 2020 07:00 ET
|
ADM Endeavors, Inc.
Fort Worth, Texas, Aug. 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADM Endeavors, Inc. (OTCQB: ADMQ) is pleased to announce that its wholly owned subsidiary, Just Right Products, Inc., has...
Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint Reducing Seizure Frequency in Children with Dravet Syndrome or Lennox-Gastaut Syndrome
August 25, 2020 07:00 ET
|
Ovid Therapeutics Inc.
Primary endpoint achieved, demonstrating a statistically significant reduction of seizures from baseline compared to placebo (p=0.0007) in the combined Dravet syndrome and Lennox-Gastaut syndrome...
MediWound and Vericel Announce Acceptance of the First Delivery of NexoBrid to BARDA for Emergency Response Preparedness
August 25, 2020 07:00 ET
|
MediWound Ltd.
YAVNE, Israel and CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) and its U.S. commercial partner Vericel Corporation (NASDAQ: VCEL) today announced that the...
The RealReal’s Annual Resale Report Reveals Top Trends in Luxury Resale
August 25, 2020 07:00 ET
|
The RealReal
SAN FRANCISCO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- The RealReal (Nasdaq: REAL)--the world’s largest online marketplace for authenticated, consigned luxury goods--today released its annual Resale...
Altimmune and the University of Alabama at Birmingham Announce Potent Respiratory Mucosal T Cell Responses in Preclinical Study of Single-Dose Intranasal COVID-19 Vaccine Candidate, AdCOVID™
August 25, 2020 07:00 ET
|
Altimmune, Inc.
GAITHERSBURG, Md., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced additional positive results from the preclinical...
Progressive Care Reports July 2020 Performance Data: $3.62M in Gross Sales, and 106% Monthly Growth in 340B Income
August 25, 2020 07:00 ET
|
Progressive Care, Inc.
MIAMI, FL, Aug. 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company,...
- May 25, 2024 09:40 ET Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
- May 24, 2024 20:18 ET Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Biogen Inc. (BIIB)